Back to Newsroom

StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer

NEWARK, Calif., March 24, 2015 (GLOBE NEWSWIRE) — StemCells, Inc.(Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, today announced that Ian Massey, D. Phil., has joined its executive team as President and Chief Operating Officer, effective March 23, 2015. In this new role, Dr. Massey has direct responsibility for all aspects of the Company’s research and development, manufacturing, regulatory affairs, and quality assurance activities. He reports to Martin McGlynn, the Company’s Chief Executive Officer.

Click here to read more